- Home
- CCG vs CUE Comparison
CCG vs CUE Comparison
Compare CCG & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- CUE
- Stock Information
- Founded
- CCG 2014
- CUE 2014
- Country
- CCG China
- CUE United States
- Employees
- CCG N/A
- CUE N/A
- Industry
- CCG
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- CUE Health Care
- Exchange
- CCG Nasdaq
- CUE Nasdaq
- Market Cap
- CCG 64.8M
- CUE 77.3M
- IPO Year
- CCG N/A
- CUE 2018
- Fundamental
- Price
- CCG $0.76
- CUE $1.07
- Analyst Decision
- CCG
- CUE Strong Buy
- Analyst Count
- CCG 0
- CUE 5
- Target Price
- CCG N/A
- CUE $5.00
- AVG Volume (30 Days)
- CCG 154.6K
- CUE 378.2K
- Earning Date
- CCG 11-26-2024
- CUE 11-14-2024
- Dividend Yield
- CCG N/A
- CUE N/A
- EPS Growth
- CCG N/A
- CUE N/A
- EPS
- CCG N/A
- CUE N/A
- Revenue
- CCG $478,620,143.00
- CUE $9,532,000.00
- Revenue This Year
- CCG $4.89
- CUE $105.39
- Revenue Next Year
- CCG $2.74
- CUE N/A
- P/E Ratio
- CCG N/A
- CUE N/A
- Revenue Growth
- CCG 4.67
- CUE 149.53
- 52 Week Low
- CCG $0.56
- CUE $0.45
- 52 Week High
- CCG $10.00
- CUE $3.20
- Technical
- Relative Strength Index (RSI)
- CCG 38.55
- CUE 45.52
- Support Level
- CCG $0.81
- CUE $0.92
- Resistance Level
- CCG $0.90
- CUE $1.09
- Average True Range (ATR)
- CCG 0.05
- CUE 0.11
- MACD
- CCG -0.01
- CUE 0.00
- Stochastic Oscillator
- CCG 11.49
- CUE 45.71
About CCG Cheche Group Inc.
Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.